Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Radius Health ("Radius") today announced topline Phase 2 data demonstrating that in women with osteoporosis, BA058 -- the company's novel PTHrP (parathyroid hormone-related protein) analog -- significantly increased
bone mineral density (BM...
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
Cardiovascular Safety and Potential Benefits of Exenatide to be Prospectively Assessed in Large Outcomes Trial
NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced results from a meta-analysis of ...
Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
RECORD trial also demonstrates durable blood sugar control over time with Avandia
LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular ...
Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
- Phase 3 study has demonstrated that Induction Chemotherapy prior to ChemoRadiotherapy significantly increased
time-to-treatment failure in comparison to standard ChemoRadiotherapy alone -
MADRID, May 30 /PRNewswire/ -- The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced toda...
MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
Results Showing Burden of RSV Disease Presented at Pediatric Academic Societies' Annual Meeting
BALTIMORE, May 5 /PRNewswire/ -- MedImmune today announced results from a recent study it sponsored, performed by the Kaiser Permanente Division of Research in Oakland, CA, assessing risk factors f...
Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
INDIANAPOLIS, April 8 /PRNewswire-FirstCall/ -- Phase III data, published online this week in the Journal of Clinical Endocrinology & Metabolism , showed that arzoxifene, an investigational selective estrogen receptor modulator (SERM) being developed by Eli Lilly and Company (NYSE: LLY ), s...
Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows
- Journal of Clinical Lipidology publishes largest study comparing cancer risk of ezetimibe and ezetimibe/simvastatin to statin therapies using FDA database -
BOSTON, March 25 /PRNewswire-USNewswire/ -- A new study shows no increased
cancer risk with ezetimibe mono and ezetimibe/simvastatin c...
CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
SUNNYVALE, Calif., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radi...
Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects
Data Support Case for DNA-Guided Medicine in Psychiatry
HARTFORD, Conn., Dec. 9 /PRNewswire/ -- Results from a clinical study published in the current issue of the Future Medicine Group (London) journal Personalized Medicine (Vol. 5, No. 6, pp. 579-587, 2008) are helping to point the ...
Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients
SAN FRANCISCO, Dec. 8 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN )
today released updated results from the ongoing, open-label extension study of
the long-term safety and efficacy of Nplate(TM) (romiplostim) in adult
patients with chronic immune thrombocytopenic purpura (ITP). Chronic IT...
Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
SAN FRANCISCO, Dec. 6 /PRNewswire/ -- Researchers today report that after the implementation of Medicare coverage limitations for erythropoiesis-stimulating agents (ESAs), a significantly greater proportion of anemic cancer patients who were on chemotherapy and who received ESAs needed blood trans...
GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
PHILADELPHIA, Dec. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK )
announced positive safety and efficacy results from RAISE (RAndomized placebo-
controlled ITP Study with Eltrombopag), a Phase III study of PROMACTA(R)
(eltrombopag) in adults with chronic immune (idiopathic) thrombocyto...
Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
Clinical trial data for Perforomist(TM) Solution presented at
International CHEST Conference
PHILADELPHIA, Oct. 29 /PRNewswire-USNewswire/ -- Data from a Phase IIIb
clinical trial demonstrate that Perforomist(TM) (formoterol fumarate)
Inhalation Solution nebulized treatment provided prolonge...
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM ) announced today that data presented this
week demonstrated that in Pfizer Inc's (NYSE: PFE ) phase III trial of
Selzentry(TM) (maraviroc) in treatment naive individuals with CCR5-tropic
Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA
2008 Annual Meeting
WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP ) today reported a data analysis showing that
vicriviroc, its investigational CCR5 receptor antagonist, demonstrate...
Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
BRIDGEWATER, N.J., Sept. 17 /PRNewswire/ -- Ortho Biotech has become
aware of preliminary data from an investigator-initiated experimental study
of the effects of Epoetin alfa in patients with acute ischemic stroke. In
this study, patients suffering acute ischemic stroke who were treated with
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
MEXICO CITY, Aug. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:
GSK) (GSK) announced today that a review of data from over 14,600 patients
in 54 clinical studies showed no increased
risk of myocardial infarction
associated with the anti-HIV medication abacavir. GSK conducted this review
Body Contouring Surgery Risk Rises with Increased Body Mass Index
Study reveals close correlation between degree of obesity and
complications arising from popular aesthetic surgical procedure
NEW YORK, July 31 /PRNewswire-USNewswire/ -- A recent study
investigating the relationship between complications of body contouring
surgery and body mass index has co...
Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection
Healthcare Facility Infection Prevention and Control Professionals Cite
Greatest Needs for Continued Success to Combat MRSA Including Additional
Staff, More Environmental Services and Time-Saving High Tech Solutions
DENVER, June 17 /PRNewswire-USNewswire/ -- More than three out of four
Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
CHICAGO, June 1 /PRNewswire/ -- Physicians at the Karmanos Cancer
Institute today presented the conclusions of their study, Risk of Second
Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of
the Surveillance, Epidemiology, and End Result (SEER) Registry at the
Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma
Updated Clinical Phase 2 data presented at American Society of Clinical Oncology Annual Meeting
PRINCETON, N.J., June 1 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) today announced updated long-term follow-up and overall
survival (OS) results from a Phase 2 c...
Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
New Data to be Presented at ASCO Shows Survival Benefit in Complete and Partial Responders Compared with Chemotherapy Alone
BERKELEY HEIGHTS, N.J., May 29 /PRNewswire-FirstCall/ -- Genta
Incorporated (OTC Bulletin Board: GNTA) announced the results of long-term
followup from a Phase 3...
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
PHILADELPHIA, May 13 /PRNewswire-USNewswire/ -- In women at increased
risk for breast cancer, adding a screening ultrasound examination to
routine mammography revealed 28 percent more cancers than mammography
alone. However, the additional ultrasound exam substantially increased
rates of f...
BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
- BiPar Sciences Presents First Peer-Reviewed Preclinical Results for BSI-201 at 2008 AACR Annual Meeting -
SAN DIEGO, April 14 /PRNewswire/ -- BiPar Sciences, Inc. today
announced positive preclinical data demonstrating the activity of its lead
poly ADP-ribose polymerase (PAR...
Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
SAN CARLOS, Calif., April 9, 2008 /PRNewswire-FirstCall/ -- Nektar
Therapeutics (Nasdaq: NKTR ) announced today that it has ceased all
negotiations with potential partners for its inhaled insulin programs as a
result of new data analysis from ongoing clinical trials conducted by
Pfizer Inc. A...
Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
National Psoriasis Foundation urges psoriasis patients to take control
of their health, help work for a cure
PORTLAND, Ore., Dec. 19 /PRNewswire-USNewswire/ -- A study released
this week showing that people with severe psoriasis are likely to have a
shorter life expectancy should prompt th...
FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
WILMINGTON, Del., Dec. 10 /PRNewswire-FirstCall/ -- The US Food and
Drug Administration (FDA) today issued its final assessment of two small,
open, long-term, clinical studies in patients with gastro-esophageal reflux
disease (GERD), comparing anti-reflux surgery with either omeprazole
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Multi-national study compared FORTEO and the currently approved therapy Fosamax for the treatment of Glucocorticoid-Induced Osteoporosis
INDIANAPOLIS, Nov. 14 /PRNewswire-FirstCall/ -- New data, published
today in The New England Journal of Medicine, showed that in patients with
Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
ORLANDO, Fla., Nov. 6 /PRNewswire/ -- What and When Additional results from the clinical trial, CHICAGO (Carotid
intima-media tHICkness in Atherosclerosis using pioGlitazOne), will be
presented as an oral session at the American Heart Association Scientific
Sessions 2007 being held November ...
'Superbug' Outbreak Calls for Immediate Increased Attention on Infection Control
NEW YORK, Oct. 31 /PRNewswire/ -- A recent outbreak of MRSA
(Methicillin- resistant Staphylococcus aureus) bacteria, often referred to
as "the superbug," should cause organizations and facilities nationwide to
reevaluate and redouble their infection control efforts. The superbug is resistant ...
EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
Results Consistent with MKC-1 Akt-mTOR Inhibitor Mechanism
ROCKVILLE, Md., Oct. 25 /PRNewswire-FirstCall/ -- EntreMed, Inc.
(Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing
therapeutics for the treatment of cancer and inflammatory diseases, today
announced the presen...
Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
- Phase III data published in the American Journal of Nephrology -
DEERFIELD, Ill., Sept. 20 /PRNewswire-FirstCall/ -- Astellas Pharma US,
Inc. today announced that its Phase III data on VAPRISOL was published in
the September issue of the American Journal of Nephrology. In this study,
Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
Paradigm Shift Needed to Ensure Americans Seek Vaccination Now Through
the Fall and Winter Months
WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- New data, released
today by the Centers for Disease Control and Prevention (CDC), show
alarmingly low influenza vaccination rates in both adults a...
Alzheimer's Growth Shows Need for Increased FDA Funding
Coalition for a Stronger FDA says drug review programs need more
WASHINGTON, March 21, 2007 /PRNewswire-USNewswire/ -- A new
estimate by the Alzheimer's Association shows that more than five
million Americans are living with Alzheimer's disease -- a 10
percent growth over previous estimates ...
New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory
Properties and Increased Health Benefits
- Bifantis shows ability to limit inflammation in models of
arthritis and Salmonella infection, according to data presented at
Digestive Disease Week -
WASHINGTON, May 21, 2007 /PRNewswire/ -- The biotechnology
company Alimentary Health today announced results from two studies
that demonstrate the...
Velcade (bortezomib) for Injection Based Induction Therapy
Delivered High Post-Transplant Complete Remission Rate, a Critical
Marker for Increased Overall Survival
- New Data from Phase III Intergroupe Francophone du Myelome (IFM)
Trial Presented During IMW -
CAMBRIDGE, Mass., July 02, 2007 /PRNewswire-FirstCall/ --
Millennium Pharmaceuticals, Inc. today reported that new data were
presented on the comparative Phase III clinical trial evaluating a
Regular Yoga Practice Is Associated With Mindful Eating
...people and may promote weight loss in those who are overweight. At the time, the researchers suspected that the weight-loss effect had more to do with increased
body awareness, specifically a sensitivity to hunger and satiety than the physical activity of yoga practice itself.
The follow-up study, publi...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...rectal carcinoma is based on progression-free survival. Currently no data are available that demonstrate an improvement in disease-related symptoms or increased
survival with Vectibix. Vectibix has not shown a treatment benefit for patients whose tumors had KRAS mutations in codon 12 or 13.
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...ts statement of operations for the three and six months ended June 30, 2009 increased
by $1.7 million and $3.3 million compared to an increase of $1.5 million an...f 2009 when it sold the stock it held in OncoGenex. OncoGenex' stock price increased
significantly in the second quarter of 2009 after announcing encouraging da...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...an be sold in or outside the US; Novavax's pilot plant facility is subject to extensive validation and FDA inspections, which may result in delays and increased
costs; the success of the Company's foreign joint venture and licensing agreements; the Company's ability to enter into future collaborations with ind...